Company Sector

Generics

Generics includes companies whose business depends heavily on off-patent drug competition, manufacturing execution, and product portfolio breadth. This category is less about a single pipeline event and more about launch timing, pricing, and operational discipline.

Why watch Generics

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Generics news

The latest feed items from companies currently grouped under Generics.

  1. 01
  2. 02

    AMRXAmneal to Report Second Quarter 2026 Results on July 30, 2026

    Source: Amneal Pharmaceuticals

  3. 03
  4. 04

    ALVOViðskipti stjórnenda og tengdra aðila

    Source: Alvotech

  5. 05
  6. 06
  7. 07
  8. 08
  9. 09
  10. 10

    ALVOViðskipti stjórnenda og tengdra aðila

    Source: Alvotech

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    ALVOViðskipti stjórnenda og tengdra aðila

    Source: Alvotech

  19. 19
  20. 20

Companies in Generics

8 companies tagged with Generics.

Frequently Asked Questions

What does the Generics sector include?

Generics includes companies whose business depends heavily on off-patent drug competition, manufacturing execution, and product portfolio breadth. This category is less about a single pipeline event and more about launch timing, pricing, and operational discipline.

How many companies are currently tagged with Generics?

8 companies are currently grouped under Generics on BioPharmSignal.

Which companies are most visible in the Generics group right now?

ALVO, AMGN, AMRX, ANIP are among the companies currently shown on this sector page.

How can I watch news for Generics?

Use the Watch button on this page to subscribe to Generics headlines and related company updates through your BioPharmSignal saved filters.

What kinds of updates usually appear for Generics?

The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Generics.